New Drugs

Brand/Generic Company Description
Addyi
flibanserin
Sprout (U.S.)/Therapeutic Pro

A serotonin agonist/antagonist for premenopausal women with hypoactive sexual desire disorder.

Afluria Tetra
influenza vaccine
Seqirus

Quadrivalent influenza vaccine for preventing influenza.

Aimovig
erenumab
Novartis

A calcitonin gene-related peptide receptor antagonist for migraine prevention.

Alphanate
antihemophilic/von Willebrand factor
Grifols Canada

For prevention and treatment of bleeding in von Willebrand disease.

Alunbrig
brigatinib
Takeda

A kinase inhibitor for a certain type of non-small cell lung cancer.

Besponsa
inotuzumab ozogamicin
Pfizer

A CD22-directed antibody-drug conjugate for advanced B-cell precursor acute lymphoblastic leukemia.

Bevespi Aerosphere
glycopyrronium/formoterol
AstraZeneca

New LAMA/LABA combination inhaler for COPD.

Biktarvy
bictegravir/emtricitabine/tenofovir alafenamide
Gilead Sciences

A combination drug for HIV-1 infection.

Cabometyx
cabozantinib
Ipsen Biopharm.

An oral tyrosine kinase inhibitor for advanced renal cell carcinoma.

Contrave
naltrexone/bupropion
Valeant

A combination opioid antagonist and antidepressant for weight management.

Cutaquig
immunoglobulin G
Octapharma

Human immunoglobulin given by SC infusion for primary or secondary immune deficiency.

Erleada
apalutamide
Janssen

An androgen receptor inhibitor for non-metastatic, castration-resistant prostate cancer.

Eucrisa
crisaborole
Pfizer

A topical PDE-4 inhibitor for mild/moderate atopic dermatitis.

Fasenra
benralizumab
Astra Zeneca

A monoclonal antibody for add-on maintenance treatment of severe eosinophilic asthma.

Folotyn
pralatrexate
Servier

An IV folate inhibitor for treatment of relapsed/refractory peripheral T-cell lymphoma.

Hadlima
adalimumab
Samsung Bioepis/ Merck

First biosimilar to Humira.

Hemlibra
emicizumab
Hoffmann-La Roche

Treatment to reduce the frequency of bleeding episodes in hemophilia A.

Jivi
antihemophilic factor
Bayer

A PEGylated antihemophilic factor for treatment/prevention of bleeding in hemophilia A.

Kisqali
ribociclib
Novartis

A kinase inhibitor for postmenopausal women with advanced breast cancer.

Kymriah
tisagenlecleucel
Novartis

T-cell immunotherapy for B-cell acute lymphoblastic leukemia or B-cell lymphoma.

Lapelga
pegfilgrastim
Apotex

First biosimilar to Neulasta.

Lonsurf
trifluridine/tipiracil
Taiho Pharma

New oral combination formulation for metastatic colorectal cancer.

Mar-Cidofovir
cidofovir
Marcan

An IV antiviral for CMV retinitis in adults with AIDS.

Mezera
mesalazine
Avir Pharma

A rectal foam enema for ulcerative colitis and rectal suppository for ulcerative proctitis.

Mvasi
bevacizumab
Amgen

A biosimilar to Avastin, for colorectal & non-small cell lung cancer.

Nuceiva
prabotulinumtoxinA
Evolus (U.S.)

A neuromuscular blocking agent for temporarily improving forehead frown lines.

Olumiant
baricitinib
Lilly

An oral Janus kinase inhibitor for rheumatoid arthritis.

Orilissa
elagolix
AbbVie

A gonadotropin-releasing hormone receptor antagonist for pain associated with endometriosis.

Ozempic
semaglutide
Novo Nordisk

A GLP-1 agonist for type 2 diabetes.

Panhematin
hemin
Recordati Rare Diseases

An IV porphyrin synthesis inhibitor for recurrent attacks of acute intermittent porphyria related to the menstrual cycle.

Penthrox
methoxyflurane
Purdue Pharma

A self-administered inhaled anesthetic/analgesic for short-term relief of moderate to severe acute pain.

Pifeltro
doravirine
Merck

An NNRTI antiretroviral agent for HIV-1 infection.

Radicava
edaravone
Mitsubishi Tanabe

An intravenous treatment for amyotrophic lateral sclerosis (ALS).

Rekovelle
follitropin delta
Ferring

A recombinant human FSH for ovarian stimulation.

Siliq
brodalumab
Valeant

An IL-17RA blocker for moderate to severe plaque psoriasis.

Steglatro
ertugliflozin
Merck

An SGLT2 inhibitor for type 2 diabetes.

Symdeko
ivacaftor/tezacaftor
Vertex

A combination formulation for cystic fibrosis.

Symtuza
darunavir/cobicistat/emtricitabine/ tenofovir alafenamide
Janssen

New combination regimen for HIV-1 infection.

Takhzyro
lanadelumab
Shire

A plasma kallikrein inhibitor for routine prevention of hereditary angioedema attacks.

Tegsedi
inotersen
Akcea (US)/Innomar

An antisense oligonucleotide for polyneuropathy of hereditary transthyretin-mediated amyloidosis.

Trelegy Ellipta
fluticasone furoate/umeclidinium/vilanterol
GSK

A new combination oral inhaler for COPD.

Velphoro
sucroferric oxyhydroxide
Vifor Fresenius/Innomar Strate

A chewable, calcium-free phosphate binder.

Veltassa
patiromer
Vifor Fresenius

An oral potassium binder for hyperkalemia.

Xermelo
telotristat
Ipsen Biopharm

An oral tryptophan hydroxylase inhibitor for refractory carcinoid syndrome diarrhea.

Xydalba
dalbavancin
Cipher

A single-dose IV lipoglycopeptide antibiotic for acute bacterial skin/skin structure infections.

Brand/Generic Company Description
Arbesda
fluticasone/salmeterol
Teva

A steroid/LABA combination oral inhaler for asthma.

Bevespi Aerosphere
glycopyrronium/formoterol
AstraZeneca

New LAMA/LABA combination inhaler for COPD.

Contrave
naltrexone/bupropion
Valeant

A combination opioid antagonist and antidepressant for weight management.

Fucibet
betamethasone/fusidic acid
Leo Pharma

An antibiotic/steroid topical cream for eczema.

Juluca
rilpivirine/ dolutegravir
ViiV Healthcare

New combination formulation for HIV-1 infection.

Mezera
mesalazine
Avir Pharma

A rectal foam enema for ulcerative colitis and rectal suppository for ulcerative proctitis.

Monoferric
iron isomaltoside 1000
Pharmacosmos/Pfizer

IV iron for iron deficiency anemia in adults.

Probuphine
buprenorphine
Knight Therapeutics

A partial opioid agonist subdermal implant for management of opioid dependence.

Rayaldee
calcifediol
Vifor Fresenius/Innomar Strat

A vitamin D3 analogue for secondary hyperparathyroidism in patients with chronic kidney disease.

Segluromet
ertugliflozin/ metformin
Merck

An SGLT2 inhibitor/biguanide combo for use in type 2 diabetes.

Soliqua
insulin glargine/lixisenatide
Sanofi-Aventis

An insulin/GLP-1 agonist combination for type 2 diabetes.

Steglujan
ertugliflozin/ sitagliptin
Merck

An SGLT2 inhibitor/DPP-4 inhibitor combination for type 2 diabetes.

Stromectol
ivermectin
Merck

An oral antiparasitic for intestinal strongyloidiasis and onchocerciasis.

Symtuza
darunavir/cobicistat/emtricitabine/tenofovir alafenamide Janssen
Janssen

New combination regimen for HIV-1 infection.

Trelegy Ellipta
fluticasone furoate/umeclidinium/vilanterol
GSK

A new combination oral inhaler for COPD.

Xultophy
insulin degludec/liraglutide
Novo Nordisk

A combination long-acting insulin and GLP-1 agonist for type 2 diabetes.

Zinbryta
daclizumab
Biogen

Voluntary withdrawal due to safety concerns, including reports of severe liver damage and immune-related conditions.

Brand/Generic Company Description
Zinbryta
daclizumab
Biogen

Voluntary withdrawal due to safety concerns, including reports of severe liver damage and immune-related conditions.